Home > Products > CD3 & CD38
> Recombinant Anti-CD3 x Anti-CD38 Bispecific Antibody (scIgG)
Recombinant Anti-CD3 x Anti-CD38 Bispecific Antibody (scIgG) (CAT#: SCIGG-192)
Recombinant Anti-CD3 x Anti-CD38 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD3 and anti-CD38 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can block two receptors simultaneously. It is designed for the research of Multiple myeloma (MM) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CD38 Bispecific Antibody (scIgG) (SCIGG-192). Click the button below to contact us or submit your feedback about this product.